Mark Massaro
Stock Analyst at BTIG
(2.32)
# 2,998
Out of 4,456 analysts
1012
Total ratings
37.4%
Success rate
0.6%
Average return
Main Sectors:
Stocks Rated by Mark Massaro
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NTRA Natera | Reiterated: Buy | $260 → $270 | $261.91 | +3.09% | 78 | Jun 23, 2026 | |
| SOPH SOPHiA GENETICS | Reiterated: Buy | $8 | $5.75 | +39.13% | 18 | Jun 15, 2026 | |
| TEM Tempus AI | Reiterated: Buy | $80 | $56.14 | +42.50% | 10 | Jun 1, 2026 | |
| GH Guardant Health | Reiterated: Buy | $145 → $160 | $149.22 | +7.22% | 47 | May 27, 2026 | |
| IMDX Insight Molecular Diagnostics | Reiterated: Hold | n/a | $5.40 | - | 23 | May 15, 2026 | |
| LUCD Lucid Diagnostics | Reiterated: Buy | $2.5 | $1.08 | +131.48% | 24 | May 15, 2026 | |
| TKNO Alpha Teknova | Reiterated: Hold | n/a | $5.75 | - | 12 | May 14, 2026 | |
| MXCT MaxCyte | Reiterated: Hold | n/a | $1.24 | - | 29 | May 13, 2026 | |
| MDXH MDxHealth | Reiterated: Buy | $7 → $4 | $0.4268 | +837.21% | 14 | May 13, 2026 | |
| CSTL Castle Biosciences | Reiterated: Buy | $50 → $40 | $24.30 | +64.61% | 34 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 → $8 | $4.58 | +74.67% | 25 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 → $11 | $13.02 | -15.51% | 37 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $38 → $32 | $18.50 | +72.97% | 5 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $140 → $130 | $118.17 | +10.01% | 5 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 | $20.96 | +4.96% | 41 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $170 → $90 | $69.82 | +28.90% | 35 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $4 | $2.92 | +36.99% | 24 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $14.17 | - | 34 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 → $28 | $28.82 | -2.85% | 32 | Apr 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Sell | $9 → $5 | $10.25 | -51.22% | 27 | Mar 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $160 | $76.09 | +110.28% | 12 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $830 → $800 | $551.50 | +45.06% | 60 | Feb 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $1.14 | - | 19 | Aug 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $2 | $1.18 | n/a | 20 | May 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0005 | n/a | 53 | Sep 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0001 | n/a | 25 | Dec 6, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $70 → $75 | $13.79 | n/a | 57 | Nov 17, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $7 → $8 | $4.46 | n/a | 48 | Nov 10, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $35 | $4.32 | n/a | 11 | Nov 6, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $300 → $310 | $176.55 | n/a | 50 | Oct 24, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $173 → $170 | $271.47 | n/a | 43 | Oct 24, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $112 → $113 | $209.88 | n/a | 41 | Oct 22, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $2.3 → $1 | $0.44155 | n/a | 13 | May 23, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $8 → $4 | $28.57 | n/a | 4 | Feb 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $149 → $145 | $155.92 | n/a | 2 | May 7, 2015 |
Natera
Jun 23, 2026
Reiterated: Buy
Price Target: $260 → $270
Current: $261.91
Upside: +3.09%
SOPHiA GENETICS
Jun 15, 2026
Reiterated: Buy
Price Target: $8
Current: $5.75
Upside: +39.13%
Tempus AI
Jun 1, 2026
Reiterated: Buy
Price Target: $80
Current: $56.14
Upside: +42.50%
Guardant Health
May 27, 2026
Reiterated: Buy
Price Target: $145 → $160
Current: $149.22
Upside: +7.22%
Insight Molecular Diagnostics
May 15, 2026
Reiterated: Hold
Price Target: n/a
Current: $5.40
Upside: -
Lucid Diagnostics
May 15, 2026
Reiterated: Buy
Price Target: $2.5
Current: $1.08
Upside: +131.48%
Alpha Teknova
May 14, 2026
Reiterated: Hold
Price Target: n/a
Current: $5.75
Upside: -
MaxCyte
May 13, 2026
Reiterated: Hold
Price Target: n/a
Current: $1.24
Upside: -
MDxHealth
May 13, 2026
Reiterated: Buy
Price Target: $7 → $4
Current: $0.4268
Upside: +837.21%
Castle Biosciences
May 13, 2026
Reiterated: Buy
Price Target: $50 → $40
Current: $24.30
Upside: +64.61%
May 12, 2026
Reiterated: Buy
Price Target: $9 → $8
Current: $4.58
Upside: +74.67%
May 11, 2026
Maintained: Buy
Price Target: $13 → $11
Current: $13.02
Upside: -15.51%
May 7, 2026
Reiterated: Buy
Price Target: $38 → $32
Current: $18.50
Upside: +72.97%
May 7, 2026
Maintained: Buy
Price Target: $140 → $130
Current: $118.17
Upside: +10.01%
May 6, 2026
Reiterated: Buy
Price Target: $22
Current: $20.96
Upside: +4.96%
May 5, 2026
Reiterated: Buy
Price Target: $170 → $90
Current: $69.82
Upside: +28.90%
May 1, 2026
Upgraded: Buy
Price Target: $4
Current: $2.92
Upside: +36.99%
Apr 30, 2026
Reiterated: Hold
Price Target: n/a
Current: $14.17
Upside: -
Apr 29, 2026
Reiterated: Buy
Price Target: $26 → $28
Current: $28.82
Upside: -2.85%
Mar 12, 2026
Rated: Sell
Price Target: $9 → $5
Current: $10.25
Upside: -51.22%
Feb 26, 2026
Reiterated: Buy
Price Target: $160
Current: $76.09
Upside: +110.28%
Feb 3, 2026
Reiterated: Buy
Price Target: $830 → $800
Current: $551.50
Upside: +45.06%
Aug 22, 2025
Reiterated: Hold
Price Target: n/a
Current: $1.14
Upside: -
May 20, 2024
Maintained: Buy
Price Target: $2
Current: $1.18
Upside: n/a
Sep 22, 2023
Rated: Hold
Price Target: n/a
Current: $0.0005
Upside: n/a
Dec 6, 2019
Rated: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Nov 17, 2019
Maintained: Buy
Price Target: $70 → $75
Current: $13.79
Upside: n/a
Nov 10, 2019
Maintained: Hold
Price Target: $7 → $8
Current: $4.46
Upside: n/a
Nov 6, 2019
Maintained: Buy
Price Target: $35
Current: $4.32
Upside: n/a
Oct 24, 2019
Maintained: Hold
Price Target: $300 → $310
Current: $176.55
Upside: n/a
Oct 24, 2019
Maintained: Hold
Price Target: $173 → $170
Current: $271.47
Upside: n/a
Oct 22, 2019
Maintained: Buy
Price Target: $112 → $113
Current: $209.88
Upside: n/a
May 23, 2018
Downgraded: Hold
Price Target: $2.3 → $1
Current: $0.44155
Upside: n/a
Feb 9, 2016
Reiterated: Hold
Price Target: $8 → $4
Current: $28.57
Upside: n/a
May 7, 2015
Maintained: Hold
Price Target: $149 → $145
Current: $155.92
Upside: n/a